Global Opthalmic Pharmaceutical Drugs Market Insights, Forecast to 2031

Report ID: 1666957 | Published Date: Oct 2024 | No. of Page: 111 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
1 Study Coverage
    1.1 Opthalmic Pharmaceutical Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Opthalmic Pharmaceutical Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Anti-glaucoma
        1.2.3 Anti-infection
        1.2.4 Anti-inflammatory
        1.2.5 Anti-allergy
    1.3 Market by Application
        1.3.1 Global Opthalmic Pharmaceutical Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Drug Stores
        1.3.4 Online Pharmacies
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Opthalmic Pharmaceutical Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Opthalmic Pharmaceutical Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Opthalmic Pharmaceutical Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Opthalmic Pharmaceutical Drugs Sales by Region
        2.4.1 Global Opthalmic Pharmaceutical Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Opthalmic Pharmaceutical Drugs by Region (2023-2028)
    2.5 Global Opthalmic Pharmaceutical Drugs Revenue by Region
        2.5.1 Global Opthalmic Pharmaceutical Drugs Revenue by Region (2017-2022)
        2.5.2 Global Opthalmic Pharmaceutical Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Opthalmic Pharmaceutical Drugs Sales by Manufacturers
        3.1.1 Global Top Opthalmic Pharmaceutical Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Opthalmic Pharmaceutical Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Opthalmic Pharmaceutical Drugs in 2021
    3.2 Global Opthalmic Pharmaceutical Drugs Revenue by Manufacturers
        3.2.1 Global Opthalmic Pharmaceutical Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Opthalmic Pharmaceutical Drugs Revenue in 2021
    3.3 Global Opthalmic Pharmaceutical Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Opthalmic Pharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Opthalmic Pharmaceutical Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Opthalmic Pharmaceutical Drugs Sales by Type
        4.1.1 Global Opthalmic Pharmaceutical Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Opthalmic Pharmaceutical Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Opthalmic Pharmaceutical Drugs Revenue by Type
        4.2.1 Global Opthalmic Pharmaceutical Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Opthalmic Pharmaceutical Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Opthalmic Pharmaceutical Drugs Price by Type
        4.3.1 Global Opthalmic Pharmaceutical Drugs Price by Type (2017-2022)
        4.3.2 Global Opthalmic Pharmaceutical Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Opthalmic Pharmaceutical Drugs Sales by Application
        5.1.1 Global Opthalmic Pharmaceutical Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Opthalmic Pharmaceutical Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Opthalmic Pharmaceutical Drugs Revenue by Application
        5.2.1 Global Opthalmic Pharmaceutical Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Opthalmic Pharmaceutical Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Opthalmic Pharmaceutical Drugs Price by Application
        5.3.1 Global Opthalmic Pharmaceutical Drugs Price by Application (2017-2022)
        5.3.2 Global Opthalmic Pharmaceutical Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Opthalmic Pharmaceutical Drugs Market Size by Type
        6.1.1 North America Opthalmic Pharmaceutical Drugs Sales by Type (2017-2028)
        6.1.2 North America Opthalmic Pharmaceutical Drugs Revenue by Type (2017-2028)
    6.2 North America Opthalmic Pharmaceutical Drugs Market Size by Application
        6.2.1 North America Opthalmic Pharmaceutical Drugs Sales by Application (2017-2028)
        6.2.2 North America Opthalmic Pharmaceutical Drugs Revenue by Application (2017-2028)
    6.3 North America Opthalmic Pharmaceutical Drugs Market Size by Country
        6.3.1 North America Opthalmic Pharmaceutical Drugs Sales by Country (2017-2028)
        6.3.2 North America Opthalmic Pharmaceutical Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Opthalmic Pharmaceutical Drugs Market Size by Type
        7.1.1 Europe Opthalmic Pharmaceutical Drugs Sales by Type (2017-2028)
        7.1.2 Europe Opthalmic Pharmaceutical Drugs Revenue by Type (2017-2028)
    7.2 Europe Opthalmic Pharmaceutical Drugs Market Size by Application
        7.2.1 Europe Opthalmic Pharmaceutical Drugs Sales by Application (2017-2028)
        7.2.2 Europe Opthalmic Pharmaceutical Drugs Revenue by Application (2017-2028)
    7.3 Europe Opthalmic Pharmaceutical Drugs Market Size by Country
        7.3.1 Europe Opthalmic Pharmaceutical Drugs Sales by Country (2017-2028)
        7.3.2 Europe Opthalmic Pharmaceutical Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Opthalmic Pharmaceutical Drugs Market Size by Type
        8.1.1 Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Opthalmic Pharmaceutical Drugs Market Size by Application
        8.2.1 Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Opthalmic Pharmaceutical Drugs Market Size by Region
        8.3.1 Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Opthalmic Pharmaceutical Drugs Market Size by Type
        9.1.1 Latin America Opthalmic Pharmaceutical Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Opthalmic Pharmaceutical Drugs Revenue by Type (2017-2028)
    9.2 Latin America Opthalmic Pharmaceutical Drugs Market Size by Application
        9.2.1 Latin America Opthalmic Pharmaceutical Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Opthalmic Pharmaceutical Drugs Revenue by Application (2017-2028)
    9.3 Latin America Opthalmic Pharmaceutical Drugs Market Size by Country
        9.3.1 Latin America Opthalmic Pharmaceutical Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Opthalmic Pharmaceutical Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Opthalmic Pharmaceutical Drugs Market Size by Type
        10.1.1 Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Opthalmic Pharmaceutical Drugs Market Size by Application
        10.2.1 Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Opthalmic Pharmaceutical Drugs Market Size by Country
        10.3.1 Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Johnson & Johnson
        11.1.1 Johnson & Johnson Corporation Information
        11.1.2 Johnson & Johnson Overview
        11.1.3 Johnson & Johnson Opthalmic Pharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Johnson & Johnson Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Johnson & Johnson Recent Developments
    11.2 Carl-Zeiss
        11.2.1 Carl-Zeiss Corporation Information
        11.2.2 Carl-Zeiss Overview
        11.2.3 Carl-Zeiss Opthalmic Pharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Carl-Zeiss Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Carl-Zeiss Recent Developments
    11.3 Ellex Medical Lasers
        11.3.1 Ellex Medical Lasers Corporation Information
        11.3.2 Ellex Medical Lasers Overview
        11.3.3 Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Ellex Medical Lasers Recent Developments
    11.4 Essilor International
        11.4.1 Essilor International Corporation Information
        11.4.2 Essilor International Overview
        11.4.3 Essilor International Opthalmic Pharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Essilor International Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Essilor International Recent Developments
    11.5 Hoya Corporation
        11.5.1 Hoya Corporation Corporation Information
        11.5.2 Hoya Corporation Overview
        11.5.3 Hoya Corporation Opthalmic Pharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Hoya Corporation Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Hoya Corporation Recent Developments
    11.6 Insight Vision
        11.6.1 Insight Vision Corporation Information
        11.6.2 Insight Vision Overview
        11.6.3 Insight Vision Opthalmic Pharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Insight Vision Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Insight Vision Recent Developments
    11.7 Nidek
        11.7.1 Nidek Corporation Information
        11.7.2 Nidek Overview
        11.7.3 Nidek Opthalmic Pharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Nidek Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Nidek Recent Developments
    11.8 Novagali Pharma
        11.8.1 Novagali Pharma Corporation Information
        11.8.2 Novagali Pharma Overview
        11.8.3 Novagali Pharma Opthalmic Pharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Novagali Pharma Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Novagali Pharma Recent Developments
    11.9 Topcon Corporation
        11.9.1 Topcon Corporation Corporation Information
        11.9.2 Topcon Corporation Overview
        11.9.3 Topcon Corporation Opthalmic Pharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Topcon Corporation Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Topcon Corporation Recent Developments
    11.10 Ziemer Ophthalmic Systems
        11.10.1 Ziemer Ophthalmic Systems Corporation Information
        11.10.2 Ziemer Ophthalmic Systems Overview
        11.10.3 Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Ziemer Ophthalmic Systems Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Opthalmic Pharmaceutical Drugs Industry Chain Analysis
    12.2 Opthalmic Pharmaceutical Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Opthalmic Pharmaceutical Drugs Production Mode & Process
    12.4 Opthalmic Pharmaceutical Drugs Sales and Marketing
        12.4.1 Opthalmic Pharmaceutical Drugs Sales Channels
        12.4.2 Opthalmic Pharmaceutical Drugs Distributors
    12.5 Opthalmic Pharmaceutical Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Opthalmic Pharmaceutical Drugs Industry Trends
    13.2 Opthalmic Pharmaceutical Drugs Market Drivers
    13.3 Opthalmic Pharmaceutical Drugs Market Challenges
    13.4 Opthalmic Pharmaceutical Drugs Market Restraints
14 Key Findings in The Global Opthalmic Pharmaceutical Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Opthalmic Pharmaceutical Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Anti-glaucoma
    Table 3. Major Manufacturers of Anti-infection
    Table 4. Major Manufacturers of Anti-inflammatory
    Table 5. Major Manufacturers of Anti-allergy
    Table 6. Global Opthalmic Pharmaceutical Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Opthalmic Pharmaceutical Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Opthalmic Pharmaceutical Drugs Sales by Region (2017-2022) & (Kg)
    Table 9. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Region (2017-2022)
    Table 10. Global Opthalmic Pharmaceutical Drugs Sales by Region (2023-2028) & (Kg)
    Table 11. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Region (2023-2028)
    Table 12. Global Opthalmic Pharmaceutical Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Region (2017-2022)
    Table 14. Global Opthalmic Pharmaceutical Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Region (2023-2028)
    Table 16. Global Opthalmic Pharmaceutical Drugs Sales by Manufacturers (2017-2022) & (Kg)
    Table 17. Global Opthalmic Pharmaceutical Drugs Sales Share by Manufacturers (2017-2022)
    Table 18. Global Opthalmic Pharmaceutical Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Opthalmic Pharmaceutical Drugs Revenue Share by Manufacturers (2017-2022)
    Table 20. Opthalmic Pharmaceutical Drugs Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 21. Global Opthalmic Pharmaceutical Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Opthalmic Pharmaceutical Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opthalmic Pharmaceutical Drugs as of 2021)
    Table 23. Opthalmic Pharmaceutical Drugs Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Opthalmic Pharmaceutical Drugs Product Offered
    Table 25. Date of Manufacturers Enter into Opthalmic Pharmaceutical Drugs Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Opthalmic Pharmaceutical Drugs Sales by Type (2017-2022) & (Kg)
    Table 28. Global Opthalmic Pharmaceutical Drugs Sales by Type (2023-2028) & (Kg)
    Table 29. Global Opthalmic Pharmaceutical Drugs Sales Share by Type (2017-2022)
    Table 30. Global Opthalmic Pharmaceutical Drugs Sales Share by Type (2023-2028)
    Table 31. Global Opthalmic Pharmaceutical Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Opthalmic Pharmaceutical Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Opthalmic Pharmaceutical Drugs Revenue Share by Type (2017-2022)
    Table 34. Global Opthalmic Pharmaceutical Drugs Revenue Share by Type (2023-2028)
    Table 35. Opthalmic Pharmaceutical Drugs Price by Type (2017-2022) & (USD/Kg)
    Table 36. Global Opthalmic Pharmaceutical Drugs Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 37. Global Opthalmic Pharmaceutical Drugs Sales by Application (2017-2022) & (Kg)
    Table 38. Global Opthalmic Pharmaceutical Drugs Sales by Application (2023-2028) & (Kg)
    Table 39. Global Opthalmic Pharmaceutical Drugs Sales Share by Application (2017-2022)
    Table 40. Global Opthalmic Pharmaceutical Drugs Sales Share by Application (2023-2028)
    Table 41. Global Opthalmic Pharmaceutical Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Opthalmic Pharmaceutical Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Opthalmic Pharmaceutical Drugs Revenue Share by Application (2017-2022)
    Table 44. Global Opthalmic Pharmaceutical Drugs Revenue Share by Application (2023-2028)
    Table 45. Opthalmic Pharmaceutical Drugs Price by Application (2017-2022) & (USD/Kg)
    Table 46. Global Opthalmic Pharmaceutical Drugs Price Forecast by Application (2023-2028) & (USD/Kg)
    Table 47. North America Opthalmic Pharmaceutical Drugs Sales by Type (2017-2022) & (Kg)
    Table 48. North America Opthalmic Pharmaceutical Drugs Sales by Type (2023-2028) & (Kg)
    Table 49. North America Opthalmic Pharmaceutical Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Opthalmic Pharmaceutical Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Opthalmic Pharmaceutical Drugs Sales by Application (2017-2022) & (Kg)
    Table 52. North America Opthalmic Pharmaceutical Drugs Sales by Application (2023-2028) & (Kg)
    Table 53. North America Opthalmic Pharmaceutical Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Opthalmic Pharmaceutical Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Opthalmic Pharmaceutical Drugs Sales by Country (2017-2022) & (Kg)
    Table 56. North America Opthalmic Pharmaceutical Drugs Sales by Country (2023-2028) & (Kg)
    Table 57. North America Opthalmic Pharmaceutical Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Opthalmic Pharmaceutical Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Opthalmic Pharmaceutical Drugs Sales by Type (2017-2022) & (Kg)
    Table 60. Europe Opthalmic Pharmaceutical Drugs Sales by Type (2023-2028) & (Kg)
    Table 61. Europe Opthalmic Pharmaceutical Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Opthalmic Pharmaceutical Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Opthalmic Pharmaceutical Drugs Sales by Application (2017-2022) & (Kg)
    Table 64. Europe Opthalmic Pharmaceutical Drugs Sales by Application (2023-2028) & (Kg)
    Table 65. Europe Opthalmic Pharmaceutical Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Opthalmic Pharmaceutical Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Opthalmic Pharmaceutical Drugs Sales by Country (2017-2022) & (Kg)
    Table 68. Europe Opthalmic Pharmaceutical Drugs Sales by Country (2023-2028) & (Kg)
    Table 69. Europe Opthalmic Pharmaceutical Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Opthalmic Pharmaceutical Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Type (2017-2022) & (Kg)
    Table 72. Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Type (2023-2028) & (Kg)
    Table 73. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Application (2017-2022) & (Kg)
    Table 76. Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Application (2023-2028) & (Kg)
    Table 77. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Region (2017-2022) & (Kg)
    Table 80. Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Region (2023-2028) & (Kg)
    Table 81. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Opthalmic Pharmaceutical Drugs Sales by Type (2017-2022) & (Kg)
    Table 84. Latin America Opthalmic Pharmaceutical Drugs Sales by Type (2023-2028) & (Kg)
    Table 85. Latin America Opthalmic Pharmaceutical Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Opthalmic Pharmaceutical Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Opthalmic Pharmaceutical Drugs Sales by Application (2017-2022) & (Kg)
    Table 88. Latin America Opthalmic Pharmaceutical Drugs Sales by Application (2023-2028) & (Kg)
    Table 89. Latin America Opthalmic Pharmaceutical Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Opthalmic Pharmaceutical Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Opthalmic Pharmaceutical Drugs Sales by Country (2017-2022) & (Kg)
    Table 92. Latin America Opthalmic Pharmaceutical Drugs Sales by Country (2023-2028) & (Kg)
    Table 93. Latin America Opthalmic Pharmaceutical Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Opthalmic Pharmaceutical Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Type (2017-2022) & (Kg)
    Table 96. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Type (2023-2028) & (Kg)
    Table 97. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Application (2017-2022) & (Kg)
    Table 100. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Application (2023-2028) & (Kg)
    Table 101. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Country (2017-2022) & (Kg)
    Table 104. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Country (2023-2028) & (Kg)
    Table 105. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Johnson & Johnson Corporation Information
    Table 108. Johnson & Johnson Description and Major Businesses
    Table 109. Johnson & Johnson Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 110. Johnson & Johnson Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Johnson & Johnson Recent Developments
    Table 112. Carl-Zeiss Corporation Information
    Table 113. Carl-Zeiss Description and Major Businesses
    Table 114. Carl-Zeiss Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 115. Carl-Zeiss Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Carl-Zeiss Recent Developments
    Table 117. Ellex Medical Lasers Corporation Information
    Table 118. Ellex Medical Lasers Description and Major Businesses
    Table 119. Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 120. Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Ellex Medical Lasers Recent Developments
    Table 122. Essilor International Corporation Information
    Table 123. Essilor International Description and Major Businesses
    Table 124. Essilor International Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 125. Essilor International Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Essilor International Recent Developments
    Table 127. Hoya Corporation Corporation Information
    Table 128. Hoya Corporation Description and Major Businesses
    Table 129. Hoya Corporation Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 130. Hoya Corporation Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Hoya Corporation Recent Developments
    Table 132. Insight Vision Corporation Information
    Table 133. Insight Vision Description and Major Businesses
    Table 134. Insight Vision Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 135. Insight Vision Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Insight Vision Recent Developments
    Table 137. Nidek Corporation Information
    Table 138. Nidek Description and Major Businesses
    Table 139. Nidek Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 140. Nidek Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Nidek Recent Developments
    Table 142. Novagali Pharma Corporation Information
    Table 143. Novagali Pharma Description and Major Businesses
    Table 144. Novagali Pharma Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 145. Novagali Pharma Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Novagali Pharma Recent Developments
    Table 147. Topcon Corporation Corporation Information
    Table 148. Topcon Corporation Description and Major Businesses
    Table 149. Topcon Corporation Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 150. Topcon Corporation Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Topcon Corporation Recent Developments
    Table 152. Ziemer Ophthalmic Systems Corporation Information
    Table 153. Ziemer Ophthalmic Systems Description and Major Businesses
    Table 154. Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 155. Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Ziemer Ophthalmic Systems Recent Developments
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Opthalmic Pharmaceutical Drugs Distributors List
    Table 160. Opthalmic Pharmaceutical Drugs Customers List
    Table 161. Opthalmic Pharmaceutical Drugs Market Trends
    Table 162. Opthalmic Pharmaceutical Drugs Market Drivers
    Table 163. Opthalmic Pharmaceutical Drugs Market Challenges
    Table 164. Opthalmic Pharmaceutical Drugs Market Restraints
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Opthalmic Pharmaceutical Drugs Product Picture
    Figure 3. Global Opthalmic Pharmaceutical Drugs Market Share by Type in 2021 & 2028
    Figure 3. Anti-glaucoma Product Picture
    Figure 4. Anti-infection Product Picture
    Figure 5. Anti-inflammatory Product Picture
    Figure 6. Anti-allergy Product Picture
    Figure 7. Global Opthalmic Pharmaceutical Drugs Market Share by Application in 2021 & 2028
    Figure 8. Hospital Pharmacies
    Figure 9. Drug Stores
    Figure 10. Online Pharmacies
    Figure 11. Others
    Figure 12. Opthalmic Pharmaceutical Drugs Report Years Considered
    Figure 13. Global Opthalmic Pharmaceutical Drugs Sales 2017-2028 (Kg)
    Figure 14. Global Opthalmic Pharmaceutical Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Opthalmic Pharmaceutical Drugs Revenue 2017-2028 (US$ Million)
    Figure 16. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Region (2017-2022)
    Figure 18. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Region (2023-2028)
    Figure 19. North America Opthalmic Pharmaceutical Drugs Sales YoY (2017-2028) & (Kg)
    Figure 20. North America Opthalmic Pharmaceutical Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Opthalmic Pharmaceutical Drugs Sales YoY (2017-2028) & (Kg)
    Figure 22. Europe Opthalmic Pharmaceutical Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Opthalmic Pharmaceutical Drugs Sales YoY (2017-2028) & (Kg)
    Figure 24. Asia-Pacific Opthalmic Pharmaceutical Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Opthalmic Pharmaceutical Drugs Sales YoY (2017-2028) & (Kg)
    Figure 26. Latin America Opthalmic Pharmaceutical Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Opthalmic Pharmaceutical Drugs Sales YoY (2017-2028) & (Kg)
    Figure 28. Middle East & Africa Opthalmic Pharmaceutical Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Opthalmic Pharmaceutical Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Opthalmic Pharmaceutical Drugs in the World: Market Share by Opthalmic Pharmaceutical Drugs Revenue in 2021
    Figure 31. Global Opthalmic Pharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2017-2028)
    Figure 33. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Type (2017-2028)
    Figure 34. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2017-2028)
    Figure 35. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Application (2017-2028)
    Figure 36. North America Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2017-2028)
    Figure 37. North America Opthalmic Pharmaceutical Drugs Revenue Market Share by Type (2017-2028)
    Figure 38. North America Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2017-2028)
    Figure 39. North America Opthalmic Pharmaceutical Drugs Revenue Market Share by Application (2017-2028)
    Figure 40. North America Opthalmic Pharmaceutical Drugs Sales Share by Country (2017-2028)
    Figure 41. North America Opthalmic Pharmaceutical Drugs Revenue Share by Country (2017-2028)
    Figure 42. U.S. Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2017-2028)
    Figure 45. Europe Opthalmic Pharmaceutical Drugs Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2017-2028)
    Figure 47. Europe Opthalmic Pharmaceutical Drugs Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Opthalmic Pharmaceutical Drugs Sales Share by Country (2017-2028)
    Figure 49. Europe Opthalmic Pharmaceutical Drugs Revenue Share by Country (2017-2028)
    Figure 50. Germany Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. France Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Opthalmic Pharmaceutical Drugs Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue Share by Region (2017-2028)
    Figure 61. China Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. India Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Opthalmic Pharmaceutical Drugs Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Opthalmic Pharmaceutical Drugs Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Opthalmic Pharmaceutical Drugs Sales Share by Country (2017-2028)
    Figure 76. Latin America Opthalmic Pharmaceutical Drugs Revenue Share by Country (2017-2028)
    Figure 77. Mexico Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue Share by Country (2017-2028)
    Figure 86. Turkey Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Opthalmic Pharmaceutical Drugs Revenue (2017-2028) & (US$ Million)
    Figure 89. Opthalmic Pharmaceutical Drugs Value Chain
    Figure 90. Opthalmic Pharmaceutical Drugs Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Johnson & Johnson
Carl-Zeiss
Ellex Medical Lasers
Essilor International
Hoya Corporation
Insight Vision
Nidek
Novagali Pharma
Topcon Corporation
Ziemer Ophthalmic Systems
Frequently Asked Questions
Opthalmic Pharmaceutical Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Opthalmic Pharmaceutical Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Opthalmic Pharmaceutical Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports